Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

APOBEC3G Antikörper (C-Term)

APOBEC3G Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN543434
  • Target Alle APOBEC3G Antikörper anzeigen
    APOBEC3G (Apolipoprotein B mRNA Editing Enzyme, Catalytic Polypeptide-Like 3G (APOBEC3G))
    Bindungsspezifität
    • 15
    • 13
    • 10
    • 9
    • 8
    • 7
    • 6
    • 6
    • 6
    • 5
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    C-Term
    Reaktivität
    • 90
    • 3
    • 2
    • 1
    Human
    Wirt
    • 84
    • 5
    • 1
    Kaninchen
    Klonalität
    • 88
    • 2
    Polyklonal
    Konjugat
    • 37
    • 10
    • 9
    • 9
    • 7
    • 7
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser APOBEC3G Antikörper ist unkonjugiert
    Applikation
    • 84
    • 53
    • 38
    • 14
    • 13
    • 13
    • 7
    • 3
    • 2
    • 2
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
    Verwendungszweck
    Rabbit polyclonal antibody raised against synthetic peptide of APOBEC3G.
    Kreuzreaktivität
    Human
    Immunogen
    A synthetic peptide (conjugated with KLH) corresponding to C-terminus of humanAPOBEC3G.
    Top Product
    Discover our top product APOBEC3G Primärantikörper
  • Applikationshinweise
    Western Blot (1:1000)
    Immunohistochemistry (1:50-100)
    The optimal working dilution should be determined by the end user.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    In PBS (0.09 % sodium azide)
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    Store at 4°C. For long term storage store at -20°C.
    Aliquot to avoid repeated freezing and thawing.
  • Mangeat, Turelli, Caron, Friedli, Perrin, Trono: "Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts." in: Nature, Vol. 424, Issue 6944, pp. 99-103, (2003) (PubMed).

    Stopak, de Noronha, Yonemoto, Greene: "HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability." in: Molecular cell, Vol. 12, Issue 3, pp. 591-601, (2003) (PubMed).

    Kao, Khan, Miyagi, Plishka, Buckler-White, Strebel: "The human immunodeficiency virus type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity." in: Journal of virology, Vol. 77, Issue 21, pp. 11398-407, (2003) (PubMed).

  • Target
    APOBEC3G (Apolipoprotein B mRNA Editing Enzyme, Catalytic Polypeptide-Like 3G (APOBEC3G))
    Andere Bezeichnung
    APOBEC3G (APOBEC3G Produkte)
    Synonyme
    A3G antikoerper, ARCD antikoerper, ARP-9 antikoerper, ARP9 antikoerper, CEM-15 antikoerper, CEM15 antikoerper, bK150C2.7 antikoerper, dJ494G10.1 antikoerper, apolipoprotein B mRNA editing enzyme catalytic subunit 3G antikoerper, APOBEC3G antikoerper
    Gen-ID
    60489
Sie sind hier:
Kundenservice